Education
About Us
Working with TipRanks
Follow Us
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
Crispr Therapeutics AG (CRSP) Ownership Overview
2.66% Insiders
14.77% Mutual Funds
19.57% Other Institutional Investors
19.53% ETFs
43.47% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail, and individual investors. Approximately 53.87% of the company’s stock is owned by Institutional Investors, 2.66% is owned by Insiders, and 43.47% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 08, 2025 | xxxxxxxxxxxxx | $1140600 | |
Jul 17, 2025 | xxxxxxxxxxxxx | $51499918 | |
Feb 28, 2025 | xxxxxxxxxxxxx | $313880 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $64810 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $142582 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $1490630 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $9305095 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,786,973 | Institution | 10.27% | 540,338,779 | |
| 9,351,871 | Institution | 9.81% | 516,316,798 | |
| 3,843,558 | Institution | 4.03% | 212,202,837 | |
| 2,160,335 | Institution | 2.27% | 119,272,095 | |
| 2,146,363 | Institution | 2.25% | 118,500,701 | |
| 2,038,763 | Insider | 2.14% | 112,560,105 | |
| 1,704,036 | Institution | 1.79% | 94,079,828 | |
| 1,647,885 | Institution | 1.73% | 90,979,731 | |
| 1,491,000 | Institution | 1.56% | 82,318,110 | |
| 1,334,645 | Institution | 1.40% | 73,685,750 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,146,363 | Institution | 2.25% | 118,500,701 | |
| 1,647,885 | Institution | 1.73% | 90,979,731 | |
| 1,491,000 | Institution | 1.56% | 82,318,110 | |
| 1,334,645 | Institution | 1.40% | 73,685,750 | |
| 957,432 | Institution | 1.00% | 52,859,821 | |
| 928,865 | Institution | 0.97% | 51,282,637 | |
| 911,014 | Institution | 0.96% | 50,297,083 | |
| 870,571 | Institution | 0.91% | 48,064,225 | |
| 677,809 | Institution | 0.71% | 37,421,835 | |
| 448,059 | Institution | 0.47% | 24,737,337 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,126,602 | Institution | 7.48% | 393,459,696 | |
| 2,006,334 | Institution | 2.11% | 110,769,700 | |
| 1,977,635 | Institution | 2.08% | 107,939,318 | |
| 1,868,315 | Institution | 1.96% | 103,149,671 | |
| 977,826 | Institution | 1.03% | 63,372,903 | |
| 702,165 | Institution | 0.74% | 38,766,530 | |
| 528,253 | Institution | 0.55% | 29,164,848 | |
| 438,369 | Institution | 0.46% | 23,926,180 | |
| 394,342 | Institution | 0.41% | 25,557,305 | |
| 297,803 | Institution | 0.31% | 16,254,088 |
FAQ
Who Owns Crispr Therapeutics AG (CRSP)?
According to the latest TipRanks data, approximately 19.57% of the company's stock is held by institutional investors, 2.66% is held by insiders, and 43.47% is held by retail investors.
What percentage of Crispr Therapeutics AG (CRSP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.57% of Crispr Therapeutics AG (CRSP) stock is held by institutional investors.
What percentage of Crispr Therapeutics AG (CRSP) stock is held by retail investors?
According to the latest TipRanks data, approximately 43.47% of Crispr Therapeutics AG (CRSP) stock is held by retail investors.
Who owns the most shares of Crispr Therapeutics AG (CRSP)?
Cathie Wood owns the most shares of Crispr Therapeutics AG (CRSP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.